Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 23Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 5Carcinoma, Non-Small-Cell Lung 4Brain Neoplasms 4Sarcoma 3Neoplasms 3Head and Neck Neoplasms 3Glioblastoma 3Nasopharyngeal Carcinoma 2Mouth Neoplasms 2Lung Neoplasms 2Uterine Cervical Neoplasms 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Postoperative Complications 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Meningioma 1Melanoma 1Malnutrition 1Glioma 1Fatigue 1Esophageal Neoplasms 1Chronic Periodontitis 1Barrett Esophagus 1Astrocytoma 1Adenocarcinoma 1

Interventions

Magnetic Resonance Spectroscopy 9Blood Specimen Collection 9Radiotherapy 7Surveys and Questionnaires 6Surgical Procedures, Operative 4vorasidenib 3Temozolomide 3Aminolevulinic Acid 3X-Rays 2Watchful Waiting 2Polymerase Chain Reaction 2Neuropsychological Tests 2Mental Status and Dementia Tests 2Magnetic Resonance Imaging 2Fluorodeoxyglucose F18 2Diagnostic Imaging 2Cancer Vaccines 2Amplified Fragment Length Polymorphism Analysis 2vinyltriethoxysilane 1lentiviral minigene vaccine of COVID-19 coronavirus 1gadoterate meglumine 1gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate 1fluorodopa F 18 1fluarix 1apatinib 1Ultrasonography 1Transurethral Resection of Bladder 1Trail Making Test 1Tetanus Toxoid 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Glioma × Radiation × Clear all
NCT00723827 2015-01-30

Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)

Merck Sharp & Dohme LLC

Completed
682 enrolled 10 charts
CNS

Astrocytoma, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡